Although GLP-1RAs are generally well tolerated and considered safe drugs, as they gain widespread use for obesity, rare but serious adverse effects such as gastroparesis, bowel obstruction, pancreatitis and non-arteritic anterior ischemic optic neuropathy are emerging
For a research buyer, the safe approach is simple: handle the material as a lab compound and never as a supplement
PR has received the following: consultancy and/or speaking fees (to his institution) from AbbVie, Abbott, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Novo Nordisk and Sanofi-Aventis, and research grants from AstraZeneca, Bayer and Novo Nordisk
and BAGSVRD, Denmark, Nov
Retatrutide by itself produces acceptable body composition outcomes, with most weight lost coming from fat
How much protein should I aim for each day